| 000 | 00804 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517040243.0 | ||
| 264 | 0 | _c20150626 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2015.5739 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKreuzer, Jörg | |
| 245 | 0 | 0 |
_aDosing Recommendations for New Oral Anticoagulants. _h[electronic resource] |
| 260 |
_bJAMA _c |
||
| 300 |
_a2496 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aDugi, Klaus | |
| 773 | 0 |
_tJAMA _gvol. 313 _gno. 24 _gp. 2496 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2015.5739 _zAvailable from publisher's website |
| 999 |
_c25009312 _d25009312 |
||